Related Experiment Video
Updated: Jan 22, 2026

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
Published on: July 25, 2025
Immobilizing A Moving Target: CAR T Cells Hit CD22
1Department of Hematology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. sguedan@clinic.cat.
Resistance to chimeric antigen receptor (CAR)-T cell therapy often involves cancer cells losing target antigens. Pharmacologic strategies to increase antigen expression may improve CAR-T cell effectiveness and treatment durability.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Chimeric antigen receptor (CAR)-T cell therapy shows promise in cancer treatment.
- A major challenge is therapeutic resistance, often due to target antigen loss on cancer cells.
- This antigen downregulation impairs CAR-T cell activation and long-term efficacy.
Purpose of the Study:
- To explore pharmacologic modulation of target antigen expression as a strategy to overcome CAR-T resistance.
- To investigate methods for enhancing antigen presentation on cancer cells.
- To improve the potency and durability of CAR-T cell responses.
Main Methods:
- The study likely involves in vitro and/or in vivo models of CAR-T therapy.
- Pharmacologic agents were investigated for their ability to upregulate target antigens.
- CAR-T cell activity and tumor response were assessed under modulated antigen expression conditions.
Main Results:
- Low antigen expression on cancer cells limits CAR-T cell function.
- Pharmacologic interventions can restore or enhance target antigen levels.
- Upregulating antigens may lead to improved CAR-T cell activation, persistence, and anti-tumor effects.
Conclusions:
- Pharmacologic modulation of antigen expression is a viable strategy to enhance CAR-T therapy.
- This approach offers a potential solution to antigen escape-mediated resistance.
- Targeting antigen expression could lead to more effective and durable cancer immunotherapies.
Related Concept Videos
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Magnetic Field due to Moving Charges
Consider a point charge moving with a constant velocity. Like the electric field, the magnetic field at any point is directly proportional to the magnitude of the charge and inversely proportional to the square of the distance between the source point and the field point. However, unlike the electric field, the magnetic field is always perpendicular to the plane containing the line...
Conservation of Mass in Moving, Nondeforming Control Volume
In the context of a detention basin, the conservation of mass states that the total mass of water entering the basin must equal the mass leaving the basin plus any accumulation of...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
What is Energy?

